Health-System Resilience Starts with Essential Product Availability
Resilient health systems need visibility across products, quality, suppliers, financing, regulation, and the services that depend on them.
By Arman K
Read brief
Latest briefings
All recent healthcare signals in one place
Scan the active archive by date, topic, and story context across healthcare markets, policy, technology, and care delivery.
Large Multimodal Models Need Clinical Boundaries
Large multimodal models may handle varied inputs, but health use still requires a defined purpose, evidence boundary, oversight, and safe failure route.
By Arman K
Read brief
AI Medical Device Evidence Has a Lifecycle
AI-enabled medical-device analysis should follow evidence from intended use through submission, change control, monitoring, and post-market learning.
By Arman K
Read brief
Health Workforce Planning Needs Comparable Accounts
Comparable workforce accounts help decision-makers separate supply, distribution, composition, activity, and the service capacity they can actually deploy.
By Arman K
Read brief
Neglected Tropical Disease Procurement Is a Forecasting Problem
Large-scale neglected tropical disease programmes need forecasting, national ownership, digital visibility, quality, and procurement discipline to protect continuity.
By Arman K
Read brief
Patient-Centred Metrics Make UHC More Operational
Universal health coverage becomes easier to manage when global indicators are connected to the patient’s experience of reaching and completing care.
By Arman K
Read brief
Interoperability Is Infrastructure, Not a Feature
Health interoperability creates value only when standards, governance, data meaning, workflow, identity, and accountability travel together.
By Arman K
Read brief
Public Health Procurement Needs a Quality-Assurance Gate
Public buyers protect value when quality assurance, regulatory evidence, procurement decisions, and post-market action are joined before purchase.
By Arman K
Read brief
Digital Therapeutics: Regulatory and Reimbursement Signals
Digital therapeutics are easier to evaluate when a claim is tied to a clinical outcome, a regulatory pathway, and a reimbursement route rather than an app store listing.
By Arman K
Read brief
Value-Based Care and Bundled Payment: Market Signals
Value-based care claims are easier to assess when a savings figure is tied to a defined population, a risk-adjustment method, and a measurement window.
By Arman K
Read brief
Prior Authorization Automation: Market Signals
Prior authorization automation is easier to assess when a claim is tied to a specific payer rule, a turnaround time, and an appeal outcome.
By Arman K
Read brief
Clinician Burnout and Retention Technology: Market Signals
Clinician burnout and retention tools are easier to assess when a claim is tied to a specific workflow burden, a measured time cost, and a retention outcome.
By Arman K
Read brief